Risk factors for melanoma development

Expert Review of Dermatology

Volumn 4, Issue 5, 2009, Pages 533-539

  Bataille, Veronique ^a,b  

^a WEST HERTFORDSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Melanoma; Nevus; Sun exposure

Indexed keywords

B RAF KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN P16; STEM CELL FACTOR RECEPTOR;

BREAST CARCINOMA; CANCER GENETICS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CAUCASIAN; ELASTOSIS; ENVIRONMENTAL FACTOR; ETHNICITY; GENE MUTATION; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HERITABILITY; HOMOZYGOTE; HUMAN; KERATOSIS; MALIGNANT TRANSFORMATION; MELANOMA; NEVUS; PENETRANCE; PHENOTYPE; PHOTOAGING; PREVALENCE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PUBLIC HEALTH SERVICE; RADIATION CARCINOGENESIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN BIOPSY; SKIN INJURY; SKIN PIGMENTATION; SKIN PROTECTION; SUN EXPOSURE; TUMOR SUPPRESSOR GENE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

EID: 70350660696     PISSN: 17469872     EISSN: None     Source Type: Journal    
DOI: 10.1586/edm.09.43     Document Type: Review

References (53)

1. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur. J. Cancer 44, 1345-1398 (2008).
2. Coory M, Baade P, Aitken J, Smithers M, McLeod GR, Ring I. Trends in situ and invasive melanoma in Queensland, Australia 1982-2002. Cancer Causes Control 17, 21-22 (2006).
3. Whiteman DC, Bray CA, Siskind V, Green AC, Hole DJ, Mackie RM. Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion. Eur. J. Cancer Prev. 17(3), 243-250 (2008). (Pubitemid 351549665)
4. Bliss JM, Ford D, Swerdlow AJ et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). Int. J. Cancer 62(4), 367-376 (1995).
5. Cress RD, Holly EA. Incidence of cutaneous melanoma among Hispanic whites, Hispanics, Asians and blacks. An analysis of California Cancer Registry data, 1988-1993. Cancer Causes Control 8, 246-252(1997).
6. Rouhani P, Hu S, Kirsner RS. Melanoma in Hispanics and black Americans. Cancer Control 15, 248-253 (2008).
7. Gandini S, Sera F, Cattaruzza MS et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur. J. Cancer 41(1), 45-60 (2005). (Pubitemid 40029658)
8. Bataille V, Boniol M, de Vries E et al. A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur. J. Cancer 41, 2141-2149 (2005). (Pubitemid 41337956)
9. Welch HG, Schwartz LM, Woloshin S. Are increasing 5-year survival rates evidence of success against cancer? JAMA 14(283), 2975-2978 (2000).
10. Welch HG, Woloshin S, Schwartz LM. Skin biopsy rates and incidence of melanoma: population based ecological study. BMJ 331, 481 (2005).
11. Burton RC, Coates MS, Hersey P et al. An analysis of a melanoma epidemic. Int. J. Cancer 55, 765-770 (1993).
12. Gordon L, You PH, Elwood M et al. Diagnosis and management costs of suspicious lesions from a population-based melanoma screening programme. J. Med. Screen. 14, 98-102 (2007). (Pubitemid 47067765)
13. de Vries E, Boniol M, Doré JF, Coeberg JW. Eurocare working group. Lower incidence rates but thicker melanomas in Eastern Europe preceding 1992: a comparison with Western Europe. Eur. J. Cancer 40, 1045-1052 (2004).
14. Pienta KJ. Critical appraisal of prostatespecific antigen in prostate cancer screening: 20 years later. Urology 73(5 Suppl.), S11-S20 (2009).
15. Maass N, Alkasi O, Bauer M, Jonat W, Souchon R, Meinhold-Heerlein I. Actual management of ductal carcinoma in situ of the breast. Arch. Gynecol. Obstet. DOI: 10.1007/s00404-009-0999-y (2009) (Epub ahead of print).
16. Perez-Gomez B, Aragones S, Gustavsson P et al. Does sex and site matter? Different age distribution in melanoma of the trunk in Swedish men and women. Br. J. Dermatol. 158, 766-772 (2008).
17. Scoggins CR, Ross MI, Reintgen DS et al. Gender-related differences in outcome for melanoma patients. Ann. Surg. 243, 693-698 (2006).
18. de Vries E, Nijsten E, Visser O et al. Superior survival of females amongst 10,358 Dutch melanoma patients is independent of Breslow thickness, histological type and tumour site. Ann. Oncol. 19, 583-589 (2008). (Pubitemid 351325683)
19. Autier P. Cutaneous malignant melanoma. Facts about sunbeds and sunscreens. Expert Rev. Anticancer Ther. 5(5), 821-833 (2005). (Pubitemid 41599958)
20. Bauer J, Buttner P, Wiecker TS, Luther H, Garbe C. Interventional study in 1232 young German children to prevent the development of melanocytic nevi failed to change sun exposure and sun protective behaviour. Int. J. Cancer 116, 755-761 (2005). (Pubitemid 41099706)
21. Bataille V, Kato BS, Falchi M et al. Nevus size and number are associated with telomere length and represent potential markers of a reduced senescence in vivo. Cancer Epidemiol. Biomarkers Prev. 16, 1499-1502 (2007).
22. Harrison S, MaKie RM, MacLennan R. Development of melanocytic nevi in the first three years of life. J. Natl Cancer Inst. 92, 1436-1438 (2000). (Pubitemid 30696197)
23. Bataille V, Snieder H, MacGregor AJ, Sasieni P, Spector TD. Genetics of risk factors for melanoma: an adult twin study of nevi and freckles. J. Natl Cancer Inst. 92, 457-463 (2000). (Pubitemid 30182882)
24. Wachsmuth RC, Gaut RM, Barrett JH et al. Heritability and gene-environment interactions for melanocytic nevus density examined in a UK adolescent twin study. J. Invest. Dermatol. 117, 348-352 (2001).
25. Bataille V, Grulich A, Sasieni P et al. The association between nevi and melanoma in population with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia. Br. J. Cancer 77, 505-510 (1998). (Pubitemid 28044060)
26. Gandini S, Sera F, Cattaruzza MS et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical nevi. Eur. J. Cancer 41, 28-44 (2005). (Pubitemid 40029657)
27. Chang YM, Newton-Bishop JA, Bishop DT et al. A pooled analysis of melanocytic naevus phenotype and the risk of cutaneous melanoma. Int. J. Cancer 124, 420-428 (2009).
28. Newton Bishop JA, Bataille V, Pinney L, Bishop DT. Family studies in melanoma. identification of the atypical mole syndrome (AMS) phenotype. Melanoma Res. 4, 199-206 (1994). (Pubitemid 24257666)
29. Bataille V. Genetic epidemiology of melanoma. Eur. J. Cancer 39, 1341-1347 (2003).
30. Liede A, Karlan BY, Narod SA. Cancer risks for male carriers of germline mutations in BRCA1 and BRCA 2. A review of the literature. J. Clin. Oncol. 22, 735-742 (2004). (Pubitemid 41095079)
31. Gandini S, Sera F, Cattaruza MF et al. Meta-analysis of risk factors for cutaneous melanoma: family history, actinic damage and phenotypic factors. Eur. J. Cancer 41, 2041-2059 (2005).
32. Kennedy C, ter Huume J, Berkhout M et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair colour. J. Invest. Dermatol. 117, 294-300 (2001).
33. Raimondi S, Sera F, Gandini S et al. MCR1R variants, melanoma and red hair colour phenotype: a meta-analsysis. Int. J. Cancer 122, 2753-2760 (2008). (Pubitemid 351631377)
34. Landi MT, Bauer J, Pfeiffer RM et al. MC1R germline variants confer risk for mutant-BRAF melanoma. Science 313, 521-522 (2006).
35. Bataille V, Sasieni P, Grulich A et al. Solar keratoses: a risk factor for melanoma but negative association with melanocytic nevi. Int. J. Cancer 78, 8-12 (1998).
36. Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J. Natl Cancer Inst. 95, 806-812 (2003).
37. Chang YM, Barrett JH, Bishop DT et al. Sun exposure and melanoma risk at different latitudes. A pooled analysis of 5700 cases and 7216 controls. Int. J. Epidemiol. 38, 814-830 (2009).
38. Kamb A, Shattuck-Eidens D, Eeles R et al. Analysis of the p16 (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat. Genet. 8, 23-26 (1994).
39. Bishop DT, Demenais F, Goldstein AM et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J. Natl Cancer Inst. 94, 894-903 (2002)
40. Goldstein AM, Cahn M, Harland M et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma prone families from three continents. J. Med. Genet. 44, 99-106 (2007). (Pubitemid 46318466)
41. Helsing P, Nymoen DA, Ariansen S et al. Population based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas. Genes Chromosomes Cancer 47, 175-184 (2008).
42. Newton Bishop JA, Gruis NA. Genetics: what advice for patients who present with a family history of melanoma? Semin. Oncol. 34, 452-459 (2007).
43. Sini MC, Manca A, Cossu A et al. Molecular alterations at chromosome 9p21 in melanocytic nevi and melanoma. Br. J. Dermatol. 158, 243-250 (2008).
44. Davies H, Bignell GR, Cox C et al. Mutations of the BRAF gene in human cancer. Nature 27, 949-954 (2000).
45. Maldonado JL, Fridlyand J, Patel H et al. Determinants of BRAF mutations in primary melanomas. J. Natl Cancer Inst. 97, 401-402 (2005).
46. Richmond-Sinclair NM, Lee E, Cummings MC et al. Histologic and epidemiologic correlates of PMAPK, Brn-2, p53 and p16 immunostaining in cutaneous melanoma. Melanoma Res. 18, 336-345 (2008).
47. Jonsson G, Dahl C, Sandberg T et al. Genomic profiling of malignant melanoma using tiling-resolution array CGH. Oncogene 26, 4738-4748 (2007). (Pubitemid 47067402)
48. Gudbjartsson DF, Sulem P, Stacey SN et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat. Genet. 40, 1029 (2008). (Pubitemid 351913649)
49. Brown KM, Macgregor S, Montgomery GW et al. Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat. Genet. 40, 817-818 (2008).
50. Falchi M, Bataille V, Hayward N et al. Genome wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat. Genet. 41, 915-919 (2009).
51. Bishop DT, Demenais F, Iles MM et al. Genome wide association study identifies three loci associated with melanoma risk. Nat. Genet. 41, 920-925 (2009).
52. Glass D, Lens M, Swaminathan R, Spector TD, Bataille V. Pigmentation and vitamin D in Caucasians: low vitamin D serum levels in fair skin types in the UK. PloS ONE 4, E6477 (2009).
53. SEER database - fast stats http://seer.cancer.gov/faststats/selections. php?run&output=2&data=1&statistic=2 &year=200802&race= 2&sex=1&age=1&s eries=cancer&cancer=53